Vaxcyte, Inc.(PCVX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PCVX Vaxcyte, Inc.

休市中 01-10 16:00:00 EST

81.08

+0.02

+0.02%

盘后81.08

+0.000.00%

16:20 EST

最高81.50	最低79.22	成交量102.24万
今开80.00	昨收81.06	日振幅2.81%
总市值101.06亿	流通市值93.24亿	总股本1.25亿
成交额8,248万	换手率0.89%	流通股本1.15亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"PCVX","market":"US","secType":"STK","nameCN":"Vaxcyte, Inc.","latestPrice":81.08,"timestamp":1736542800000,"preClose":81.06,"halted":0,"volume":1022449,"hourTrading":{"tag":"盘后","latestPrice":81.08,"preClose":81.08,"latestTime":"16:20 EST","volume":44360,"amount":3596708.8,"timestamp":1736544000603},"delay":0,"floatShares":114993079,"shares":124636546,"eps":-4.459734,"marketStatus":"休市中","change":0.02,"latestTime":"01-10 16:00:00 EST","open":80,"high":81.5,"low":79.22,"amount":82480265.56468,"amplitude":0.028127,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.459734,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1736758800000},"marketStatusCode":7,"adr":0,"listingDate":1591934400000,"exchange":"NASDAQ","adjPreClose":81.06,"preHourTrading":{"tag":"盘前","latestPrice":79.51,"preClose":81.06,"latestTime":"09:27 EST","volume":423,"amount":33879.4236,"timestamp":1736519260071},"postHourTrading":{"tag":"盘后","latestPrice":81.08,"preClose":81.08,"latestTime":"16:20 EST","volume":44360,"amount":3596708.8,"timestamp":1736544000603},"volumeRatio":1.1042264661434467,"impliedVol":0.7311,"impliedVolPercentile":0.8486},"requestUrl":"/m/hq/s/PCVX","defaultTab":"news","newsList":[{"id":"2502733084","title":"Vaxcyte, Inc.盘中异动 急速下跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502733084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502733084?lang=zh_cn&edition=full","pubTime":"2025-01-09 04:17","pubTimestamp":1736367466,"startTime":"0","endTime":"0","summary":"北京时间2025年01月09日04时17分，Vaxcyte, Inc.股票出现异动，股价大幅跳水5.02%。Vaxcyte, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。其相关个股中，Sana Biotechnology, Inc.、Vir Biotechnology, Inc.、Silo Pharma, Inc.涨幅较大，Silo Pharma, Inc.、Hoth Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为3601.76%、848.34%、622.85%，振幅较大的相关个股有Sana Biotechnology, Inc.、Silo Pharma, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为192.73%、156.87%、89.00%。Vaxcyte, Inc.公司简介：Vaxcyte Inc 是一家疫苗公司，致力于通过开发新型疫苗来治疗患有最常见和致命疾病的患者，从而改善全球健康状况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010904174695fd3320&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010904174695fd3320&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","PCVX","BK4139","IE0009354923.USD"],"gpt_icon":0},{"id":"2494433755","title":"Vaxcyte, Inc.盘中异动 下午盘快速下跌5.01%报81.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494433755","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494433755?lang=zh_cn&edition=full","pubTime":"2024-12-28 04:13","pubTimestamp":1735330425,"startTime":"0","endTime":"0","summary":"北京时间2024年12月28日04时13分，Vaxcyte, Inc.股票出现波动，股价快速下挫5.01%。截至发稿，该股报81.48美元/股，成交量40.3783万股，换手率0.32%，振幅4.25%。Vaxcyte, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。Vaxcyte, Inc.公司简介：Vaxcyte Inc 是一家疫苗公司，致力于通过开发新型疫苗来治疗患有最常见和致命疾病的患者，从而改善全球健康状况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241228041345ab95330c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241228041345ab95330c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCVX","IE0009354923.USD","BK4139","LU0053671581.USD"],"gpt_icon":0},{"id":"2492151849","title":"Vaxcyte, Inc.盘中异动 临近收盘快速跳水5.10%报85.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492151849","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492151849?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:45","pubTimestamp":1734554714,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时45分，Vaxcyte, Inc.股票出现异动，股价急速下挫5.10%。截至发稿，该股报85.28美元/股，成交量67.579万股，换手率0.54%，振幅6.23%。Vaxcyte, Inc.股票所在的生物技术行业中，整体跌幅为3.05%。Vaxcyte, Inc.公司简介：Vaxcyte Inc 是一家疫苗公司，致力于通过开发新型疫苗来治疗患有最常见和致命疾病的患者，从而改善全球健康状况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219044514984cb920&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219044514984cb920&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0009354923.USD","PCVX","BK4139","LU0053671581.USD"],"gpt_icon":0},{"id":"2485451114","title":"Vaxcyte, Inc.盘中异动 下午盘股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485451114","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485451114?lang=zh_cn&edition=full","pubTime":"2024-11-22 02:08","pubTimestamp":1732212530,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日02时08分，Vaxcyte, Inc.股票出现波动，股价急速拉升5.06%。截至发稿，该股报90.31美元/股，成交量87.3504万股，换手率0.70%，振幅5.69%。Vaxcyte, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。Vaxcyte, Inc.公司简介：Vaxcyte Inc 是一家疫苗公司，致力于通过开发新型疫苗来治疗患有最常见和致命疾病的患者，从而改善全球健康状况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122020850971a7f07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122020850971a7f07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0053671581.USD","IE0009354923.USD","PCVX"],"gpt_icon":0},{"id":"2483388174","title":"Vaxcyte, Inc.涨0.89% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2483388174","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483388174?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:31","pubTimestamp":1731508282,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时31分，Vaxcyte, Inc.股票出现波动，股价大幅上涨0.89%。截至发稿，该股报100.26美元/股，成交量4199股，换手率0.00%，振幅0.00%。Vaxcyte, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Vaxcyte, Inc.公司简介：Vaxcyte Inc 是一家疫苗公司，致力于通过开发新型疫苗来治疗患有最常见和致命疾病的患者，从而改善全球健康状况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322312295be2318&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322312295be2318&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","PCVX","BK4139","IE0009354923.USD"],"gpt_icon":0},{"id":"2482427491","title":"Vaxcyte, Inc.2024财年第三财季实现净利润-1.03亿美元，同比减少11.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482427491","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482427491?lang=zh_cn&edition=full","pubTime":"2024-11-10 00:02","pubTimestamp":1731168124,"startTime":"0","endTime":"0","summary":"11月10日，Vaxcyte, Inc.公布财报，公告显示公司2024财年第三财季净利润为-1.03亿美元，同比减少11.16%；其中营业收入为0.00美元，每股基本收益为-0.83美元。从资产负债表来看，Vaxcyte, Inc.总负债1.42亿美元，其中短期债务9.64百万美元，资产负债比为25.08，流动比率为17.86。机构评级：截至2024年11月10日，当前有8家机构对Vaxcyte, Inc.目标价做出预测，其中目标均价为151.75美元，其中最低目标价为135.00美元，最高目标价为163.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000225a2278625&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000225a2278625&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCVX"],"gpt_icon":0},{"id":"2481205611","title":"Vaxcyte 公司报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2481205611","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481205611?lang=zh_cn&edition=full","pubTime":"2024-11-06 12:44","pubTimestamp":1730868295,"startTime":"0","endTime":"0","summary":"   * Vaxcyte Inc   报告，截至9月30日的季度调整后每股亏损83美分，高于去年同期的每股-91美分。九位分析师对该季度的平均预期是每股亏损 1.13 美元。华尔街预期为每股亏损 1.35 美元至-88 美分。* Vaxcyte Inc公布的季度每股收益为亏损83美分。* 该公司当季亏损 1.0312 亿美元。* Vaxcyte Inc 本季度股价下跌了 6.8%，今年迄今为止上涨了 69.6%。华尔街对 Vaxcyte Inc 的 12 个月目标价中位数为 155.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Vaxcyte 公司报告截至 9 月 30 日的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","LU0053671581.USD","BK4139","PCVX"],"gpt_icon":0},{"id":"2479236716","title":"Vaxcyte, Inc.盘中异动 股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479236716","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479236716?lang=zh_cn&edition=full","pubTime":"2024-10-30 00:43","pubTimestamp":1730220190,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日00时43分，Vaxcyte, Inc.股票出现异动，股价大幅下跌5.26%。Vaxcyte, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Vaxcyte, Inc.公司简介：Vaxcyte Inc 是一家疫苗公司，致力于通过开发新型疫苗来治疗患有最常见和致命疾病的患者，从而改善全球健康状况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103000431198e3f27f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103000431198e3f27f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCVX","IE0009354923.USD","BK4139","LU0053671581.USD"],"gpt_icon":0},{"id":"2466510787","title":"美国研究综述-苹果、联邦快递、Vaxcyte","url":"https://stock-news.laohu8.com/highlight/detail?id=2466510787","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466510787?lang=zh_cn&edition=full","pubTime":"2024-09-10 15:37","pubTimestamp":1725953827,"startTime":"0","endTime":"0","summary":"    路透9月10日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Exlservice Apple、Fedex 和 Vaxcyte。* Fedex Corp   ：Stephens 将目标价从 360 美元下调至 350 美元             * Spire Global Inc   ：Canaccord Genuity恢复买入评级             * Vaxcyte Inc   ：瑞穗将目标价从 113 美元上调至 163 美元以下是路透周二报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU0158827781.USD","LU0170899867.USD","RLAY","BK4505","SHLS","APP","BK4170","BOOT","IE0004091025.USD","LU1803068979.SGD","MCFT","LU0109392836.USD","TERN","LU0320765489.SGD","EL","CUBE","BK4573","LU0742534661.SGD","BK4574","BK4183","EXR","PNC","PSA","BK4084","IE00BJJMRY28.SGD","DK","LU0861579265.USD","SPIR","LU0198837287.USD","IE00B19Z8W00.USD","IE00BKVL7J92.USD","TRGP","MEI","LU0719512351.SGD","CDMO","PCVX","BK4504","INSP","AAPL","LU0323591593.USD","FDX","RZLT","BK4503","RBRK","BK4527","TVTX","IE00B19Z8X17.USD"],"gpt_icon":1},{"id":"2465928512","title":"百亿美金的胜利，疫苗新贵崛起启示录","url":"https://stock-news.laohu8.com/highlight/detail?id=2465928512","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465928512?lang=zh_cn&edition=full","pubTime":"2024-09-05 15:55","pubTimestamp":1725522917,"startTime":"0","endTime":"0","summary":"过去几年，国产创新疫苗企业讲故事的时候，最喜欢提的一个概念是：国产替代。即，国内疫苗品种与海外疫苗品种，存在代际差距。截至目前，其进入临床的疫苗管线，只有VAX-24、VAX-31两款肺炎疫苗。9月3日，随着VAX-31积极的临床数据公布，Vaxcyte股价大涨36.39%，市值已经超过120亿美金；自2022年至今，Vaxcyte股价逆势上涨超320%。固然，13价肺炎疫苗已经给肺炎的预防，带来了划时代的改变。自引入PCV13以来，疫苗中包含的血清型引起的疾病发病率有所下降。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/239662","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU0170899867.USD","BK4592","IE00BLSP4452.SGD","SG9999011175.SGD","BK4588","BK4585","LU0225284248.USD","LU0122379950.USD","SG9999001176.USD","IE000M9KFDE8.USD","LU1023059063.AUD","IE00BLSP4239.USD","LU0321505868.SGD","IE00B19Z3581.USD","LU0058720904.USD","LU1066051498.USD","BK4139","LU0306807586.USD","SG9999002232.USD","LU1066053197.SGD","SG9999002224.SGD","BK4568","IE0002270589.USD","LU1057294990.SGD","SG9999001176.SGD","IE0009354923.USD","LU0306806265.USD","LU1883839398.USD","SG9999003800.SGD","IE00BBT3K403.USD","LU0985481810.HKD","BK4550","BK4007","PCVX","SG9999013999.USD","SGXZ57979304.SGD","BK4533","LU0868494617.USD","LU0225771236.USD","LU1894683264.USD","LU0321505439.SGD","IE00B19Z3B42.SGD","LU0289739699.SGD","LU0456855351.SGD","BK4581","LU1894683348.USD","LU0234572021.USD","BK4534"],"gpt_icon":1},{"id":"2465591206","title":"Vaxcyte 将通过出售股票和认股权证融资 13 亿美元，股价创历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2465591206","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465591206?lang=zh_cn&edition=full","pubTime":"2024-09-05 13:11","pubTimestamp":1725513109,"startTime":"0","endTime":"0","summary":"一天前，Vaxcyte公司称 ，其试验性肺炎球菌疫苗在一项早期研究中显示出良好的效果，其安全性与辉瑞公司的   Prevnar 20疫苗相似，之后该公司股价大涨48%，创下历史新高。Vaxcyte公司目前还没有任何获准上市的产品，它正致力于开发预防或治疗各种细菌性传染病的疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE0009354923.USD","PCVX"],"gpt_icon":0},{"id":"1106999389","title":"异动解读 | Vaxcyte临床进展利好 股价大涨挑战辉瑞主导地位","url":"https://stock-news.laohu8.com/highlight/detail?id=1106999389","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106999389?lang=zh_cn&edition=full","pubTime":"2024-09-04 21:34","pubTimestamp":1725456864,"startTime":"0","endTime":"0","summary":"生物技术公司Vaxcyte 周二盘中大涨超36%,主要受到其实验性肺炎球菌多糖结合疫苗VAX-31的最新临床试验数据利好消息推动。根据公告,VAX-31在1/2期成人临床试验中表现出与竞争对手辉瑞旗下PCV疫苗Prevnar 20相似的良好安全性。这一积极进展令Vaxcyte看好将VAX-31推进关键的3期临床试验,为未来申请上市做准备。若最终获批,VAX-31有望在PCV疫苗市场掀起一股新的竞争力量,挑战目前辉瑞和默克等公司的主导地位。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCVX"],"gpt_icon":0},{"id":"2464374611","title":"单日暴涨36%，Vaxcyte“剑指”辉瑞，先下一城","url":"https://stock-news.laohu8.com/highlight/detail?id=2464374611","media":"美股研究社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464374611?lang=zh_cn&edition=full","pubTime":"2024-09-04 20:02","pubTimestamp":1725451341,"startTime":"0","endTime":"0","summary":"Vaxcyte的1年低点为 44.20 美元，1年高点为 119.27 美元。Vaxcyte，Inc是一家临床阶段的生物技术疫苗公司，开发新型蛋白质疫苗来预防或治疗细菌传染病。尽管如此，但截至 2024 年 6 月，Vaxcyte 拥有 1.5b 美元的现金，没有债务。他补充说，Vaxcyte 疫苗最终可能会占领肺炎球菌疫苗市场的大部分。Jefferies Financial Group 在周二的一份报告中将 Vaxcyte 的目标价从 108.00 美元上调至 129.00 美元，并给予该公司“买入”评级。最后，BTIG Research 将 Vaxcyte 股票的目标价从 9","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409042019519edfc6b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409042019519edfc6b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B19Z3B42.SGD","SG9999002232.USD","BK4139","IE0009354923.USD","BK4550","SG9999001176.SGD","LU0058720904.USD","LU0289739699.SGD","LU1883839398.USD","BK4534","LU0985481810.HKD","LU0234572021.USD","LU0170899867.USD","LU1894683264.USD","PCVX","LU0225284248.USD","LU0321505439.SGD","IE00BBT3K403.USD","LU0225771236.USD","LU0122379950.USD","LU1894683348.USD","IE00B19Z3581.USD","BK4568","LU1023059063.AUD","IE00BLSP4239.USD","LU1066053197.SGD","PFE","SG9999003800.SGD","LU1057294990.SGD","IE0002270589.USD","LU0321505868.SGD","SGXZ57979304.SGD","BK4585","SG9999013999.USD","LU0456855351.SGD","SG9999011175.SGD","BK4533","LU1066051498.USD","BK4588","IE000M9KFDE8.USD","LU0868494617.USD","SG9999002224.SGD","LU0306806265.USD","BK4592","BK4581","BK4007","SG9999001176.USD","IE00BLSP4452.SGD","LU0306807586.USD"],"gpt_icon":1},{"id":"2464838123","title":"BUZZ--美国股票走势-沃尔格林、铜矿商、西蒙地产","url":"https://stock-news.laohu8.com/highlight/detail?id=2464838123","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464838123?lang=zh_cn&edition=full","pubTime":"2024-09-04 00:04","pubTimestamp":1725379486,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      9月3日 - 华尔街主要股指下跌超过1%，因为投资者在评估最新的工厂活动数据，本周还将公布一系列劳动力市场报告，这些报告可能会影响美联储今年放松货币政策的程度。美东时间11:48，道琼斯工业平均指数  下跌1.08%，报41,114.45 点。标普500指数  下跌1.43%，报5567.76点；纳斯达克综合指数  下跌2.39%，报17290.837点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCVX","CVX","TCOM","GOOG","NWSA","XOM","NOC","IMAX","LUV","OKE","DYN","PSQ","GOOGL","NVCR","X","L","SNGX","AAOI","BA","MNQmain","FDS","SGRP","IFF","HGmain","JAZZ","MTB","SOC",".DJI","SPG","TQQQ","MRO","WBA","DVN","DJX",".IXIC","FCX","SCCO","RXRX","CME","MUR","PSX","SQ","FANG","COP","MGM","MU","RIVN","KO","BUZZ","DKS","AQB","XYL"],"gpt_icon":1},{"id":"2464650807","title":"BUZZ-Vaxcyte 因肺炎球菌疫苗早期数据良好而创下历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2464650807","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464650807?lang=zh_cn&edition=full","pubTime":"2024-09-03 22:13","pubTimestamp":1725372800,"startTime":"0","endTime":"0","summary":" (更新)    9月3日 - ** 疫苗开发商Vaxcyte公司  的股价上涨45 .7%，达到116.62美元，创下历史最高价* * 该公司称，其试验性肺炎球菌疫苗  在一项早期研究中显示  ，安全性与竞争对手辉瑞公司  的Prevnar 20疫苗相似。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505439.SGD","LU1883839398.USD","PCVX","BK4139","SG9999002224.SGD","SG9999001176.USD","SG9999003800.SGD","SG9999001176.SGD","LU0234572021.USD","LU1066051498.USD","LU0306806265.USD","PFE","BK4568","LU0868494617.USD","LU0289739699.SGD","IE00BBT3K403.USD","BK4581","LU0058720904.USD","IE00BLSP4239.USD","LU1894683264.USD","SGXZ57979304.SGD","IE0002270589.USD","LU0321505868.SGD","LU0170899867.USD","LU0225771236.USD","LU0456855351.SGD","BK4007","LU1057294990.SGD","IE00B19Z3B42.SGD","BK4585","IE00BLSP4452.SGD","IE00B19Z3581.USD","SG9999011175.SGD","SG9999002232.USD","LU0122379950.USD","LU1023059063.AUD","BK4592","LU1894683348.USD","BK4588","SG9999013999.USD","BK4534","BK4550","LU0225284248.USD","IE0009354923.USD","BUZZ","LU1066053197.SGD","LU0306807586.USD","BK4533","LU0985481810.HKD","IE000M9KFDE8.USD"],"gpt_icon":1},{"id":"2464809275","title":"肺炎球菌疫苗的早期数据 \"前景看好\"，Vaxcyte 公司股价大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2464809275","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464809275?lang=zh_cn&edition=full","pubTime":"2024-09-03 21:22","pubTimestamp":1725369758,"startTime":"0","endTime":"0","summary":"    路透9月3日 - Vaxcyte公司  周二股价大涨30%以上，因为这家疫苗开发商称其试验性肺炎球菌疫苗在一项早期研究中显示出良好的效果，其安全性与竞争对手辉瑞公司  的疫苗相似。Vaxcyte 的股价在周二的盘前交易中上涨了 33.8%，报 108.05 美元。在数据公布前，该公司股价今年迄今已上涨 28.6%，市值约为 90 亿美元。Vaxcyte公司说，在这项研究中，所有剂量的VAX-31在整个六个月的评估期内都显示出与Prevnar 20相似的安全性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE0002270589.USD","LU0234572021.USD","BK4581","BK4007","SG9999003800.SGD","IE0009354923.USD","LU0170899867.USD","LU1066053197.SGD","SG9999011175.SGD","LU0456855351.SGD","SG9999002232.USD","BK4550","BK4568","IE00B19Z3B42.SGD","LU0225284248.USD","LU0289739699.SGD","SG9999001176.USD","SG9999002224.SGD","IE00B19Z3581.USD","IE000M9KFDE8.USD","IE00BLSP4452.SGD","BK4592","LU0058720904.USD","BK4585","BK4534","LU0306806265.USD","LU0306807586.USD","PCVX","BK4139","IE00BLSP4239.USD","IE00BBT3K403.USD","SG9999001176.SGD","BK4533","LU1894683264.USD","LU1883839398.USD","LU0868494617.USD","SG9999013999.USD","LU0321505868.SGD","LU1023059063.AUD","LU1894683348.USD","LU0122379950.USD","LU0225771236.USD","LU1057294990.SGD","LU1066051498.USD","SGXZ57979304.SGD","LU0985481810.HKD","LU0321505439.SGD"],"gpt_icon":1},{"id":"2464809220","title":"BUZZ--美国股票走势-波音公司、西南航空公司、PDD 控股公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2464809220","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464809220?lang=zh_cn&edition=full","pubTime":"2024-09-03 21:21","pubTimestamp":1725369687,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      9月3日 - 华尔街周二将低开，因为在本周将公布一系列经济数据报告之前，投资者将采取观望态度，这些数据可能会影响美联储今年放松货币政策的程度。美东时间9:09，道指电子盘  下跌0.53%，报41,431点。标普500指数小型股  下跌0.58%，报5628.25点；纳斯达克100指数小型股  下跌0.74%，报19477.25点。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1145028129.USD","SGRP","CVX","L","AQB","LU1992135399.USD","BK4548","X","LU1839511570.USD","OKE","LU0328353924.USD","LU0964807845.USD","BA","BK4526","LUV","BK4581","PDD","HGmain","MTB","SCCO","BK4527","MUR","PCVX","WBA","LU0047713382.USD","LU1496350171.SGD","SG9999015945.SGD","XYL","BK4213","IMAX","FDS","NWSA","BK4108","BK4531","LU0203345920.USD","LU2089279066.USD","LU0633140560.USD","LU0633140727.USD","XOM","BK4574","BK4109","IFF","LU1366192091.USD","FCX","BK4211","SNGX","MRO"],"gpt_icon":1},{"id":"1114403329","title":"Vaxcyte盘前飙涨，旗下疫苗显示出与辉瑞竞品相似的安全性","url":"https://stock-news.laohu8.com/highlight/detail?id=1114403329","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114403329?lang=zh_cn&edition=full","pubTime":"2024-09-03 20:53","pubTimestamp":1725368010,"startTime":"0","endTime":"0","summary":"所有剂量的VAX-31都具有良好的耐受性。","market":"us","thumbnail":"https://static.tigerbbs.com/0a40de8dddbd8ac39be91d60de4308cd","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/0a40de8dddbd8ac39be91d60de4308cd"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/content/detail/1178897.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Vaxcyte旗下疫苗显示出与辉瑞竞品相似的安全性","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["PCVX"],"gpt_icon":1},{"id":"2464870927","title":"BUZZ-Vaxcyte 因肺炎球菌疫苗早期研究结果良好而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2464870927","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464870927?lang=zh_cn&edition=full","pubTime":"2024-09-03 20:03","pubTimestamp":1725364994,"startTime":"0","endTime":"0","summary":"    9月3日 - ** 疫苗开发商Vaxcyte公司  股价盘前上涨36.5%至110.26美元 ** 公司称其试验性肺炎球菌疫苗在一项早期研究中显示出积极的效果，该研究对1,015名50岁及以上的健康成年人进行了测试，以预防侵袭性肺炎球菌疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BUZZ","IE0009354923.USD","PCVX"],"gpt_icon":0},{"id":"2458697314","title":"Vaxcyte, Inc.2024财年第二财季实现净利润-1.29亿美元，同比减少88.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458697314","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458697314?lang=zh_cn&edition=full","pubTime":"2024-08-12 00:10","pubTimestamp":1723392642,"startTime":"0","endTime":"0","summary":"8月12日，Vaxcyte, Inc.公布财报，公告显示公司2024财年第二财季净利润为-1.29亿美元，同比减少88.76%；其中营业收入为0.00美元，每股基本收益为-1.10美元。从资产负债表来看，Vaxcyte, Inc.总负债1.01亿美元，其中短期债务7.29百万美元，资产负债比为20.67，流动比率为0.18。机构评级：截至2024年8月12日，当前有7家机构对Vaxcyte, Inc.目标价做出预测，其中目标均价为103.14美元，其中最低目标价为95.00美元，最高目标价为113.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081200105395904279&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081200105395904279&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCVX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vaxcyte.com","stockEarnings":[{"period":"1week","weight":-0.0445},{"period":"1month","weight":-0.1095},{"period":"3month","weight":-0.2914},{"period":"6month","weight":-0.0159},{"period":"1year","weight":0.3513},{"period":"ytd","weight":-0.0095}],"compareEarnings":[{"period":"1week","weight":-0.0194},{"period":"1month","weight":-0.0444},{"period":"3month","weight":0.0016},{"period":"6month","weight":0.0366},{"period":"1year","weight":0.2186},{"period":"ytd","weight":-0.0095}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Vaxcyte, Inc.于2013年11月27日在特拉华州注册成立。该公司是一家下一代疫苗公司，旨在通过开发预防或治疗全球某些最常见和致命的传染病的新型疫苗来改善全球健康状况。他们的无细胞蛋白质合成平台使他们能够设计和生产蛋白质载体和抗原，这是疫苗的关键组成部分。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.040586},{"month":2,"riseRate":0.5,"avgChangeRate":0.028598},{"month":3,"riseRate":0.25,"avgChangeRate":-0.069811},{"month":4,"riseRate":0.5,"avgChangeRate":-0.00703},{"month":5,"riseRate":0.75,"avgChangeRate":0.110566},{"month":6,"riseRate":0.75,"avgChangeRate":0.01461},{"month":7,"riseRate":0.4,"avgChangeRate":0.004916},{"month":8,"riseRate":1,"avgChangeRate":0.177784},{"month":9,"riseRate":0.4,"avgChangeRate":0.074404},{"month":10,"riseRate":0.2,"avgChangeRate":0.074083},{"month":11,"riseRate":0.4,"avgChangeRate":-0.050106},{"month":12,"riseRate":0.6,"avgChangeRate":0.02337}],"exchange":"NASDAQ","name":"Vaxcyte, Inc.","nameEN":"Vaxcyte, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vaxcyte, Inc.(PCVX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Vaxcyte, Inc.(PCVX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Vaxcyte, Inc.,PCVX,Vaxcyte, Inc.股票,Vaxcyte, Inc.股票老虎,Vaxcyte, Inc.股票老虎国际,Vaxcyte, Inc.行情,Vaxcyte, Inc.股票行情,Vaxcyte, Inc.股价,Vaxcyte, Inc.股市,Vaxcyte, Inc.股票价格,Vaxcyte, Inc.股票交易,Vaxcyte, Inc.股票购买,Vaxcyte, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vaxcyte, Inc.(PCVX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Vaxcyte, Inc.(PCVX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}